Filtros de búsqueda

Lista de obras de

'No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia': authors' response

artículo científico publicado en 2017

2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans

artículo científico publicado en 2011

A 25-year-old woman with type 2 diabetes and liver disease

artículo científico publicado en 2014

A comprehensive compartmental model of blood glucose regulation for healthy and type 2 diabetic subjects

artículo científico publicado en 2015

A role for exogenous GLP-1 in the management of postprandial hypoglycaemia after Roux-en-Y gastric bypass?

artículo científico publicado en 2019

A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metabolite

artículo científico publicado en 2017

Adult atopic dermatitis and the risk of type 2 diabetes

scientific article published on 19 October 2016

Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes--focus on pancreatitis and pancreas cancer

artículo científico publicado en 2014

Albiglutide for treating type 2 diabetes: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy.

artículo científico publicado en 2015

Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes

artículo científico publicado en 2014

Antidiabetes Agents and Incident Depression: A Nationwide Population-Based Study

scientific article published on 25 September 2020

Association Between Topical Corticosteroid Use and Type 2 Diabetes in Two European Population-Based Adult Cohorts

artículo científico publicado en 2019

Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects

scientific article published on 01 February 2019

Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

artículo científico publicado en 2016

Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trials

artículo científico publicado en 2017

Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion

artículo científico

Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes.

artículo científico publicado en 2014

Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes?

artículo científico publicado en 2010

Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density

artículo científico publicado en 2018

Bone Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2 Diabetes During Oral Glucose and Isoglycemic Intravenous Glucose

Bone Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2 Diabetes During Oral Glucose and Isoglycemic Intravenous Glucose

Cardiovascular biomarkers in clinical studies of type 2 diabetes

artículo científico publicado en 2018

Cardiovascular effects of alpha-linolenic acid--a possible role of glucagon-like peptide-1.

artículo científico publicado en 2013

Cardiovascular safety and benefits of GLP-1 receptor agonists

artículo científico publicado en 2017

Cephalic phase secretion of insulin and other enteropancreatic hormones in humans

artículo científico publicado en 2015

Changes in oxidative nucleic acid modifications and inflammation following one-week treatment with the bile acid sequestrant sevelamer: Two randomised, placebo-controlled trials

artículo científico publicado en 2019

Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty

artículo científico publicado en 2013

Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs

artículo científico publicado en 2018

Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses

artículo científico publicado en 2016

Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production

artículo científico publicado en 2017

Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes

artículo científico publicado en 2020

Clearance of glucoregulatory peptide hormones during haemodialysis and haemodiafiltration in non-diabetic end-stage renal disease patients.

artículo científico publicado en 2014

Clinical Pharmacokinetics and Pharmacodynamics of Albiglutide.

artículo científico publicado en 2017

Clinical characteristics and glucose-lowering drug utilization among patients initiating liraglutide in Denmark: a routine clinical care prescription study

scientific article published on 25 April 2019

Clinical pharmacology of imeglimin for the treatment of type 2 diabetes

scientific article published on 28 February 2020

Clinical relevance of the bile acid receptor TGR5 in metabolism.

artículo científico publicado en 2016

Comment on Xu et al. Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes. Diabetes Care 2015;38:1858-1867

scientific article published on 01 December 2015

Comment on: Chen et al. utilizing the second-meal effect in type 2 diabetes: practical use of a soya-yogurt snack. Diabetes Care 2010;33:2552–2554.

artículo científico publicado en 2011

Comment on: Gögebakan et al. Glucose-dependent insulinotropic polypeptide reduces fat-specific expression and activity of 11β-hydroxysteroid dehydrogenase type 1 and inhibits release of free fatty acids. Diabetes 2012;61:292-300.

artículo científico publicado en 2012

Comment on: Villareal et al. (2009) TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action. Diabetes;59:479-485.

artículo científico publicado en 2010

Comparing olive oil and C4-dietary oil, a prodrug for the GPR119 agonist, 2-oleoyl glycerol, less energy intake of the latter is needed to stimulate incretin hormone secretion in overweight subjects with type 2 diabetes

artículo científico publicado en 2018

Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies.

artículo científico publicado en 2019

Current Therapies That Modify Glucagon Secretion: What Is the Therapeutic Effect of Such Modifications?

artículo científico publicado en 2017

Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetes.

artículo científico publicado en 2011

Decreased plasma chemerin levels in women with gestational diabetes mellitus

artículo científico publicado en 2014

Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects

artículo científico publicado en 2018

Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.

artículo científico publicado en 2016

Diabetes: Add-on to metformin in T2DM--linagliptin or glimepiride?

artículo científico publicado en 2012

Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment

artículo científico publicado en 2015

Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia.

artículo científico publicado en 2016

Diagnosis and treatment of maturity onset diabetes of the young type 3 ⬇️

artículo científico publicado en 2018

Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

scientific article published on 12 July 2018

Differential time responses in inflammatory and oxidative stress markers after a marathon: An observational study

artículo científico publicado en 2020

Disturbed postprandial glucose metabolism and gut hormone responses in non-diabetic patients with psoriasis

article

Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?

artículo científico publicado en 2010

Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.

artículo científico publicado en 2010

Duodenal L cell density correlates with features of metabolic syndrome and plasma metabolites.

artículo científico publicado en 2018

EJE PRIZE 2018: A gut feeling about glucagon.

artículo científico publicado en 2018

Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism

artículo científico publicado en 2015

Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trial

artículo científico publicado en 2016

Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure

artículo científico publicado en 2015

Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.

artículo científico publicado en 2015

Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature.

artículo científico publicado en 2016

Effect of bile acid sequestrants on glycaemic control: protocol for a systematic review with meta-analysis of randomised controlled trials

artículo científico publicado en 2012

Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion

artículo científico publicado en 2016

Effect of exercise combined with glucagon-like peptide-1 receptor agonist treatment on cardiac function: A randomized double-blind placebo-controlled clinical trial

artículo científico publicado en 2017

Effect of liraglutide on body weight and pain in patients with overweight and knee osteoarthritis: protocol for a randomised, double-blind, placebo-controlled, parallel-group, single-centre trial

artículo científico publicado en 2019

Effect of short-acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double-blind placebo-controlled trial

artículo científico publicado en 2020

Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis

artículo científico publicado en 2015

Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studies

artículo científico publicado en 2013

Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)

artículo científico publicado en 2023

Effect of the Incretin Hormones on the Endocrine Pancreas in End-Stage Renal Disease

artículo científico publicado en 2020

Effects of Smoking Versus Nonsmoking on Postprandial Glucose Metabolism in Heavy Smokers Compared With Nonsmokers

artículo científico publicado en 2018

Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study

artículo científico publicado en 2019

Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2015

Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk factors: A narrative review of head-to-head comparisons

artículo científico publicado en 2017

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

artículo científico publicado en 2012

Effects of liraglutide on cardiovascular risk factors in patients with type 1 diabetes.

artículo científico publicado en 2016

Effects of liraglutide on gallbladder emptying: A randomized, placebo-controlled trial in adults with overweight or obesity.

artículo científico publicado en 2018

Effects of lixisenatide on elevated liver transaminases: systematic review with individual patient data meta-analysis of randomised controlled trials on patients with type 2 diabetes

artículo científico publicado en 2014

Effects of sitagliptin on counter-regulatory and incretin hormones during acute hypoglycaemia in patients with type 1 diabetes: a randomized double-blind placebo-controlled crossover study

artículo científico publicado en 2015

Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)

artículo científico publicado en 2020

Efficacy and safety of fixed-ratio combination of insulin degludec and liraglutide (IDegLira) for the treatment of type 2 diabetes

artículo científico publicado en 2017

Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2015

Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 study

artículo científico publicado en 2015

Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease

artículo científico publicado en 2014

Emerging GLP-1 receptor agonists

artículo científico publicado en 2011

Enteroendocrine K and L cells in healthy and type 2 diabetic individuals

artículo científico publicado en 2017

Erratum to: Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trial.

artículo científico publicado en 2018

Erratum. Evidence of Extrapancreatic Glucagon Secretion in Man. Diabetes 2016;65:585-597

artículo científico publicado en 2016

Evaluation of the incretin effect in humans using GIP and GLP-1 receptor antagonists

scientific article published on 03 November 2019

Evidence connecting old, new and neglected glucose-lowering drugs to bile acid-induced GLP-1 secretion: A review.

artículo científico publicado en 2017

Evidence of Extrapancreatic Glucagon Secretion in Man

article

Evidence of a liver-alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids

artículo científico publicado en 2018

Exenatide: pharmacokinetics, clinical use, and future directions

artículo científico publicado en 2017

Experience of family function, family involvement, and self-management in adult patients with type 2 diabetes: A thematic analysis

scientific article published on 21 November 2019

Extrapancreatic glucagon: Present status

artículo científico publicado en 2018

FGF21, a liver hormone that inhibits alcohol intake in mice, increases in human circulation after acute alcohol ingestion and sustained binge drinking at Oktoberfest.

artículo científico publicado en 2018

Fixed combination of insulin and a glucagon-like peptide-1 analog for the treatment of type 2 diabetes, exemplified by insulin degludec and liraglutide

artículo científico

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD

artículo científico publicado en 2018

GIP and the gut-bone axis - Physiological, pathophysiological and potential therapeutic implications

scientific article published on 09 November 2019

GIP's effect on bone metabolism is reduced by the selective GIP receptor antagonist GIP(3-30)NH2

scientific article published on 14 October 2019

GIP's involvement in the pathophysiology of type 2 diabetes

scientific article published on 01 November 2019

GIP(3-30)NH2 - a tool for the study of GIP physiology

scientific article published on 11 October 2020

GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study

artículo científico publicado en 2017

GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes.

artículo científico publicado en 2016

GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations.

artículo científico

GLP-1 and Amylin in the Treatment of Obesity

artículo científico

Gastric aspiration therapy is a possible alternative to treatment of obesity ⬇️

artículo científico publicado en 2017

Gastric bypass surgery: Improving psoriasis through a GLP-1-dependent mechanism?

artículo científico publicado en 2011

Gastrin secretion in normal subjects and diabetes patients is inhibited by glucagon-like peptide 1: a role in the gastric side effects of GLP-1-derived drugs?

artículo científico publicado en 2019

Ghrelin secretion in humans - a role for the vagus nerve?

artículo científico publicado en 2018

Glimepiride monotherapy versus combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes: a protocol for a randomised, double-blinded, placebo-controlled trial

scientific article published on 03 October 2018

Glucagon Physiology

artículo científico publicado en 2000

Glucagon Receptor Signaling and Glucagon Resistance

scientific article published on 05 July 2019

Glucagon Receptor Signaling and Lipid Metabolism

scientific article published on 24 April 2019

Glucagon Resistance at the Level of Amino Acid Turnover in Obese Subjects with Hepatic Steatosis

scientific article published on 23 January 2020

Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis

scientific article published on 13 September 2020

Glucagon and Amino Acids Are Linked in a Mutual Feedback Cycle: The Liver-α-Cell Axis.

artículo científico publicado en 2017

Glucagon and type 2 diabetes: the return of the alpha cell.

artículo científico publicado en 2014

Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals

article

Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitis.

artículo científico publicado en 2010

Glucagon-like peptide 1 in health and disease

artículo científico publicado en 2018

Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits

artículo científico publicado en 2012

Glucagon-like peptide-1 receptor agonists and risk of acute pancreatitis in patients with type 2 diabetes

artículo científico publicado en 2017

Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysis

scientific article published on 07 October 2018

Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities.

artículo científico publicado en 2014

Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes

artículo científico publicado en 2010

Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology

artículo científico publicado en 2020

Gluco-metabolic effects of oral and intravenous alcohol administration in men

scientific article published on 01 October 2019

Glucometabolic hormones and cardiovascular risk markers in antipsychotic-treated patients

artículo científico

Glucose metabolism in patients with psoriasis

artículo científico publicado en 2018

Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and Glycemia

Glucose-Dependent Insulinotropic Polypeptide (GIP) Reduces Bone Resorption in Patients With Type 2 Diabetes

scientific article published on 16 July 2020

Glucose-Dependent Insulinotropic Polypeptide Is a Pancreatic Polypeptide Secretagogue in Humans

artículo científico publicado en 2020

Glucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease

artículo científico publicado en 2019

Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents

artículo científico publicado en 2018

Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes

artículo científico publicado en 2014

Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans

artículo científico publicado en 2014

Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans

artículo científico publicado en 2011

Glucose-dependent insulinotropic polypeptide: blood glucose stabilizing effects in patients with type 2 diabetes

artículo científico publicado en 2013

Glucose-lowering effects and low risk of hypoglycemia in patients with maturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double-blind, randomized, crossover trial

artículo científico publicado en 2014

Glucose-lowering effects and mechanisms of the bile acid-sequestering resin sevelamer.

artículo científico publicado en 2018

Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - pump vs multiple daily injections, a secondary analysis of an observational cohort study

artículo científico publicado en 2020

Gut Mucosal Gene Expression and Metabolic Changes After Roux-en-Y Gastric Bypass Surgery

artículo científico publicado en 2020

Gut microbiota may have influence on glucose and lipid metabolism

artículo científico publicado en 2013

Hemodynamic Effects of Glucagon - A Literature Review.

artículo científico publicado en 2018

Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals

artículo científico publicado en 2019

Higher Endogenous Glucose Production During OGTT vs Isoglycemic Intravenous Glucose Infusion

artículo científico publicado en 2016

Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?

artículo científico publicado en 2014

Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes

artículo científico publicado en 2017

Hypoglycaemia and cardiac arrhythmias in diabetes

artículo científico publicado en 2020

INPP4B protects from metabolic syndrome and associated disorders

artículo científico publicado en 2021

Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.

artículo científico publicado en 2013

Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.

artículo científico publicado en 2017

Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity

artículo científico publicado en 2012

Impaired incretin effect is an early sign of glucose dysmetabolism in nondiabetic patients with psoriasis

artículo científico publicado en 2015

Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.

artículo científico publicado en 2012

Impaired regulation of the incretin effect in patients with type 2 diabetes

artículo científico publicado en 2011

Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition.

artículo científico publicado en 2017

Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion.

artículo científico publicado en 2015

Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes

artículo científico publicado en 2010

Incidence and Prognosis of Psoriasis and Psoriatic Arthritis in Patients Undergoing Bariatric Surgery.

artículo científico publicado en 2016

Increased Postprandial Response of Glucagon-Like Peptide-2 in Patients with Chronic Pancreatitis and Pancreatic Exocrine Insufficiency

scientific article published on 12 May 2010

Increased expression of glucagon-like peptide-1 receptors in psoriasis plaques

artículo científico publicado en 2013

Increased levels of YKL-40 and interleukin 6 in patients with chronic pancreatitis and secondary diabetes

artículo científico publicado en 2012

Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects

artículo científico publicado en 2010

Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution

article

Incretin effect and glucagon responses to oral and intravenous glucose in patients with maturity-onset diabetes of the young--type 2 and type 3.

artículo científico publicado en 2014

Incretin hormones and beta cell function in chronic pancreatitis.

scientific article published on July 2010

Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes - a review

artículo científico publicado en 2010

Incretin-based therapy and type 2 diabetes

scientific article published on January 2010

Incretin-based therapy of type 2 diabetes mellitus

scientific article published on February 2009

Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosis

artículo científico publicado en 2015

Influenza Vaccination Is Associated With Reduced Cardiovascular Mortality in Adults With Diabetes: A Nationwide Cohort Study

artículo científico publicado en 2020

Investigating Intestinal Glucagon After Roux-en-Y Gastric Bypass Surgery

artículo científico publicado en 2019

Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin.

artículo científico publicado en 2016

Involvement of steatosis-induced glucagon resistance in hyperglucagonaemia

artículo científico publicado en 2015

Is glucagon-like peptide-1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?

artículo científico publicado en 2018

KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

artículo científico publicado en 2008

L-Cell Differentiation Is Induced by Bile Acids Through GPBAR1 and Paracrine GLP-1 and Serotonin Signaling

artículo científico publicado en 2020

Lack of effect of the glucagon-like peptide-1 receptor agonist liraglutide on psoriasis in glucose-tolerant patients - a randomized placebo-controlled trial

artículo científico publicado en 2014

Letter by Knop regarding article, "Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the investigation of lipid level management to understand its impact in atherosclerotic events (ILLUMINATE) trial"

artículo científico publicado en 2012

Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes.

artículo científico publicado en 2014

Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes

artículo científico publicado en 2019

Lixisenatide for the treatment of type 2 diabetes.

artículo científico

Lixisenatide for type 2 diabetes mellitus

scientific article published on 11 March 2011

Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus

artículo científico publicado en 2009

Long-acting GLP-1 analogs for the treatment of type 2 diabetes mellitus

artículo científico publicado en 2008

Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes

artículo científico publicado en 2011

Management of people with Type 2 diabetes shared between a specialized outpatient clinic and primary health care is noninferior to management in a specialized outpatient clinic: a randomized, noninferiority trial

artículo científico publicado en 2019

Mathematical Modelling of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 following Ingestion of Glucose

artículo científico publicado en 2017

Mechanism of metabolic advantages after bariatric surgery: it's all gastrointestinal factors versus it's all food restriction.

artículo científico publicado en 2013

Mechanism-Based Modeling of Gastric Emptying Rate and Gallbladder Emptying in Response to Caloric Intake

artículo científico publicado en 2016

Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes

artículo científico publicado en 2013

Metabolic profile in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives

artículo científico publicado en 2019

Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes

artículo científico publicado en 2018

Model-Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in Humans

artículo científico publicado en 2018

N-acyl taurines are endogenous lipid messengers that improve glucose homeostasis

scientific article published on 18 November 2019

N-terminally and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptor

artículo científico publicado en 2015

Near-normalization of glycaemic control with glucagon-like peptide-1 receptor agonist treatment combined with exercise in patients with type 2 diabetes

artículo científico publicado en 2016

New avenues in the regulation of gallbladder motility - implications for the use of glucagon-like peptide-derived drugs

artículo científico publicado en 2019

No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 Diabetes

scientific article published on 16 January 2020

No changes in levels of bone formation and resorption markers following a broad-spectrum antibiotic course

artículo científico publicado en 2018

No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia

artículo científico publicado en 2017

No hypoglycemia after subcutaneous administration of glucagon-like peptide-1 in lean type 2 diabetic patients and in patients with diabetes secondary to chronic pancreatitis

artículo científico publicado en 2003

Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion

artículo científico publicado en 2019

Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference.

artículo científico publicado en 2016

Normal insulin sensitivity, glucose tolerance, gut incretin and pancreatic hormone responses in adults with atopic dermatitis

scientific article published on 20 July 2020

On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes

artículo científico publicado en 2014

Once-weekly GLP-1 agonists: How do they differ from exenatide and liraglutide?

scientific article published on April 2010

One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial

artículo científico publicado en 2020

Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma

artículo científico publicado en 2016

Palaeolithic diet decreases fasting plasma leptin concentrations more than a diabetes diet in patients with type 2 diabetes: a randomised cross-over trial

artículo científico publicado en 2016

Pancreatic Amylase and Lipase Plasma Concentrations Are Unaffected by Increments in Endogenous GLP-1 Levels Following Liquid Meal Tests

artículo científico publicado en 2015

Pancreatic polypeptide responses to isoglycemic oral and intravenous glucose in humans with and without intact vagal innervation.

artículo científico publicado en 2015

Patient Assessment of Family Function, Glycemic Control and Quality of Life in Adult Patients With Type 2 Diabetes and Incipient Complications

artículo científico publicado en 2019

Patients with psoriasis are insulin resistant

artículo científico publicado en 2015

Plasma YKL-40 during pregnancy and gestational diabetes mellitus

artículo científico publicado en 2015

Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease

scientific article published on 01 March 2019

Postpartum reversibility of impaired incretin effect in gestational diabetes mellitus.

artículo científico publicado en 2013

Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes.

artículo científico publicado en 2016

Postprandial Plasma Concentrations of ProANP in Patients with Type 2 Diabetes and Healthy Controls

artículo científico publicado en 2017

Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.

artículo científico publicado en 2014

Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients

artículo científico publicado en 2012

Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young

artículo científico publicado en 2015

Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease.

artículo científico publicado en 2013

Preclinical discovery and development of colesevelam for the treatment of type 2 diabetes

article

Premature explantation of an EndoBarrier gastrointestinal liner because of sleeve invagination

artículo científico publicado en 2015

Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus

artículo científico publicado en 2009

Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial

artículo científico publicado en 2020

Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan

artículo científico publicado en 2020

Protocol for Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetes Cases (The MAG1C trial): a randomised, double-blinded, placebo-controlled trial.

artículo científico publicado en 2018

Psoriasis is associated with type 2 diabetes

artículo científico publicado en 2013

Recovery of gut microbiota of healthy adults following antibiotic exposure

scientific article published on 22 October 2018

Recovery of the incretin effect in type 2 diabetic patients after biliopancreatic diversion.

artículo científico publicado en 2015

Reduced Incretin Effect in Type 2 Diabetes

article by Filip K. Knop et al published 18 May 2007 in Diabetes

Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.

artículo científico publicado en 2010

Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus

article

Remission of Bile Acid Malabsorption Symptoms Following Treatment With the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

scientific article published on 06 April 2019

Replacing SUs with incretin-based therapies for type 2 diabetes mellitus: challenges and feasibility.

artículo científico publicado en 2008

Response to Letter to the Editor: “Hemodynamic Effects of Glucagon: A Literature Review”

artículo científico publicado en 2018

Response to the Letter: "Epidemiologic Association Between Antibiotic Use With the Risk of Developing Type 2 Diabetes" by López-Hernández, D

scientific article published on 01 November 2015

Restoration of enteroendocrine and pancreatic function after internal hernia and short bowel syndrome in a young woman with gastric bypass - a 2-year follow-up.

artículo científico publicado en 2018

Retinal vascular and structural dynamics during acute hyperglycaemia

artículo científico publicado en 2015

Risk stratification by endocrinologists of patients with type 2 diabetes in a Danish specialised outpatient clinic: a cross-sectional study

artículo científico publicado en 2016

SU18. GLP-1 Receptor Agonist Treatment in Schizophrenia Patients With Obesity.

artículo científico publicado en 2017

Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blinded, Parallel Group, Randomized Trial

artículo científico publicado en 2015

Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention study

artículo científico publicado en 2013

Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.

artículo científico

Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies

artículo científico publicado en 2013

Secretion of parathyroid hormone may be coupled to insulin secretion in humans

artículo científico publicado en 2020

Self-expanding metal stents for colonic obstruction: experiences from 104 procedures in a single center

artículo científico publicado en 2004

Semimechanistic model describing gastric emptying and glucose absorption in healthy subjects and patients with type 2 diabetes.

artículo científico publicado en 2015

Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men without Diabetes

artículo científico publicado en 2019

Separate and Combined Glucometabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide 1 in Healthy Individuals

artículo científico publicado en 2019

Serum lipidome unravels a diagnostic potential in bile acid diarrhoea

artículo científico publicado en 2023

Sevelamer in a diabetologist's perspective: a phosphate-binding resin with glucose-lowering potential.

artículo científico publicado en 2014

Shared care management of patients with type 2 diabetes across the primary and secondary healthcare sectors: study protocol for a randomised controlled trial

artículo científico publicado en 2016

Short-acting glucagon-like peptide-1 receptor agonists as add-on to insulin therapy in type 1 diabetes: A review.

artículo científico publicado en 2017

Single-Dose Metformin Enhances Bile Acid-Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes

artículo científico publicado en 2017

Sodium-glucose cotransporter 2 (SGLT-2) inhibitors for patients with Type 2 diabetes ⬇️

artículo científico publicado en 2016

Species-specific action of (Pro3)GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors

artículo científico publicado en 2015

Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans

artículo científico publicado en 2014

Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies

artículo científico publicado en 2014

Study protocol for a multicentre, randomised, parallel group, sham-controlled clinical trial investigating the effect of transcutaneous vagal nerve stimulation on gastrointestinal symptoms in people with diabetes complicated with diabetic autonomic

scientific article published on 06 January 2021

Supportive and non-supportive interactions in families with a type 2 diabetes patient: an integrative review

artículo científico publicado en 2017

The Authors Reply:

scientific article published on 01 January 2014

The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review ⬇️

artículo científico

The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double-blinded crossover trial

artículo científico publicado en 2020

The Gut: A Key to the Pathogenesis of Type 2 Diabetes?

artículo científico publicado en 2017

The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells

artículo científico publicado en 2005

The alpha-cell as target for type 2 diabetes therapy.

artículo científico publicado en 2011

The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes

artículo científico publicado en 2017

The biology of glucagon and the consequences of hyperglucagonemia.

artículo científico publicado en 2016

The design and discovery of lixisenatide for the treatment of type 2 diabetes mellitus.

artículo científico

The dilemma of Danish Christmas lunches ⬇️

artículo científico publicado en 2017

The dose-dependent efficacy of the glucose-dependent insulinotropic polypeptide receptor antagonist, GIP(3-30)NH2 , on GIP actions in humans

artículo científico publicado en 2020

The effect of a glucagon-like peptide-1 receptor agonist on glucose tolerance in women with previous gestational diabetes mellitus: protocol for an investigator-initiated, randomised, placebo-controlled, double-blinded, parallel intervention trial

artículo científico publicado en 2013

The effect of empagliflozin on oxidative nucleic acid modifications in patients with type 2 diabetes: protocol for a randomised, double-blinded, placebo-controlled trial

artículo científico publicado en 2017

The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty

artículo científico publicado en 2013

The effects of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes: protocol for a systematic review with meta-analysis of randomised trials

artículo científico publicado en 2014

The efficacy and safety of exenatide once weekly in patients with type 2 diabetes

scientific article published on 07 February 2019

The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action

artículo científico publicado en 2010

The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes

artículo científico publicado en 2016

The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects

artículo científico publicado en 2014

The impact of pancreatic enzyme supplementation on postprandial responses of glucagon-like Peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency

article

The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance

artículo científico publicado en 2007

The liver-alpha cell axis and type 2 diabetes

scientific article published on 01 October 2019

The role of efferent cholinergic transmission for the insulinotropic and glucagonostatic effects of GLP-1.

artículo científico publicado en 2015

The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.

artículo científico publicado en 2011

The spectrum of antidiabetic actions of GLP-1 in patients with diabetes

artículo científico publicado en 2009

The unobtainable placebo: control of independent clinical research by industry?

artículo científico publicado en 2012

The use of double-balloon enteroscopy in retrieving mucosal biopsies from the entire human gastrointestinal tract

artículo científico publicado en 2014

Therapy for obesity based on gastrointestinal hormones

artículo científico publicado en 2011

Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects.

artículo científico publicado en 2013

Transfer of liraglutide from blood to cerebrospinal fluid is minimal in patients with type 2 diabetes

artículo científico publicado en 2015

Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist--protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol.

artículo científico publicado en 2014

Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.

scientific article published on August 2009

Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report

artículo científico publicado en 2014

Use of Antibiotics and Risk of Type 2 Diabetes: A Population-Based Case-Control Study.

artículo científico publicado en 2015

Use of exenatide and liraglutide in Denmark: a drug utilization study.

artículo científico publicado en 2013

Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary disease

artículo científico publicado en 2020

Vagotomy and subsequent development of diabetes - A nested case-control study.

artículo científico publicado en 2016

Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies

artículo científico publicado en 2017

What is on the horizon for type 2 diabetes pharmacotherapy? - An overview of the antidiabetic drug development pipeline

artículo científico publicado en 2020

Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effect

artículo científico publicado en 2017

Worry vs. knowledge about treatment-associated hypoglycaemia and weight gain in type 2 diabetic patients on metformin and/or sulphonylurea.

artículo científico publicado en 2012

[Biomarkers of cardiovascular disease in patients with Type 2 diabetes] ⬇️

artículo científico publicado en 2019

[Duodenal-jejunal bypass sleeve - a potential alternative to bariatric surgery?] ⬇️

scientific article published on 01 September 2014

[Effect of incretin hormones GIP and GLP-1 for the pathogenesis of type 2 diabetes mellitus]

artículo científico publicado en 2007

[GLP-1-based treatment of type 2 diabetes mellitus]

scientific article published on 01 May 2007

[Glucagon-like peptide 1 analogues in the treatment of type 2 diabetes mellitus]

scientific article published on 01 August 2012

[Glucagon-like peptide 1 receptor agonists for the treatment of Type 2 diabetes] ⬇️

scientific article published on 01 March 2019

[Metformin is a possible glucagon-like peptide 1 stimulator]. ⬇️

artículo científico publicado en 2018

[The benefits of diagnostic imaging in general practice]

scientific article published on 01 February 2006

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda